Suppr超能文献

强效和选择性噻唑烷二硫酮GSK-3抑制剂的对接及构效关系研究

Docking and structure activity relationship studies of potent and selective thiazolidinethione GSK-3 inhibitors.

作者信息

Boesger Hannah, Williams Kurtis, Abdullai Sa Adatu, Hubble Brianna, Noori Mahboubeh S, Orac Crina, Amesaki Deborah K, Ghazanfari Davoud, Fairchild Emily A, Fatunbi Opeyemi O, Pritchard Joshua A, Goetz Douglas J, Hines Jennifer V, Bergmeier Stephen C

机构信息

Department of Chemistry & Biochemistry, Ohio University, Athens, OH 45701, USA.

Department of Chemical and Biomolecular Engineering, Ohio University, Athens, OH 45701, USA.

出版信息

Bioorg Med Chem Lett. 2025 Mar 1;117:130074. doi: 10.1016/j.bmcl.2024.130074. Epub 2024 Dec 16.

Abstract

Glycogen synthase kinase-3 (GSK-3) plays a key role in several biochemical pathways and is an attractive target for pharmacological intervention. We prepared a series of analogs of a highly selective thiazolidinethione inhibitor of GSK-3. The structure-activity relationship indicated a precise structural requirement for potent inhibition. We used docking and bioinformatic analysis to explore the rationale for the potency and selectivity of this class of GSK-3 inhibitors. These computational studies identified residues unique to GSK-3 likely to play a role in ligand-specific induced fit interactions. Together, these studies highlight the structural stringency of specific kinase inhibition that can be achieved for GSK-3.

摘要

糖原合酶激酶-3(GSK-3)在多种生化途径中起关键作用,是药物干预的一个有吸引力的靶点。我们制备了一系列GSK-3高选择性噻唑烷硫酮抑制剂的类似物。构效关系表明了强效抑制的精确结构要求。我们使用对接和生物信息学分析来探究这类GSK-3抑制剂的效力和选择性的原理。这些计算研究确定了GSK-3特有的残基,这些残基可能在配体特异性诱导契合相互作用中发挥作用。总之,这些研究突出了可实现的针对GSK-3的特定激酶抑制的结构严格性。

相似文献

本文引用的文献

2
A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies.糖原合酶激酶-3(GSK3)抑制剂在癌症治疗中的研究进展。
Int J Biol Macromol. 2023 Dec 31;253(Pt 7):127375. doi: 10.1016/j.ijbiomac.2023.127375. Epub 2023 Oct 13.
3
Glycogen synthase kinase-3: A potential target for diabetes.糖原合酶激酶-3:糖尿病的一个潜在靶点。
Bioorg Med Chem. 2023 Sep 7;92:117406. doi: 10.1016/j.bmc.2023.117406. Epub 2023 Jul 6.
7
Pharmacological properties of indirubin and its derivatives.靛玉红及其衍生物的药理学性质。
Biomed Pharmacother. 2022 Jul;151:113112. doi: 10.1016/j.biopha.2022.113112. Epub 2022 May 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验